Sanofi Aventis Deutschland vs. Amgen - ORD_39859/2024

The UPC Case ORD_39859/2024 was filed on 04 Jul, 2024 by the plaintiff Sanofi Aventis Deutschland, Sanofi Aventis Deutschland, Sanofi Aventis Groupe, and others against the defendant Amgen, Amgen.

Case Details

    Case Number:

    ORD_39859/2024

    Patent Number:

    Filing Date:

    04 Jul, 2024

    Proceeding Type:

    Order

    Action/Application:

    Generic Order

    Plaintiffs:

    • Sanofi Aventis Deutschland
    • Sanofi-Aventis Deutschland Gmbh
    • Sanofi Aventis Groupe
    • Sanofi-Aventis Groupe
    • Sanofi Winthrop Industrie
    • Sanofi Winthrop Industrie S.A.

    Plaintiff Representatives:

    • Daniel Wise

    Defendants:

    • Amgen
    • Amgen Inc.

    Defendant Representatives:

    • Koen Bijvank

Case Decision

Decision pending - set alert to receive updates

Docket Entries

No docket found - set alert to stay updated on new entries.

More cases involving Sanofi Aventis Deutschland

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_33148/2025Jul 17, 2025Sanofi Aventis DeutschlandStada Arzneimittel, Stada Nordic, Stadapharm
ORD_22245/2025May 11, 2025Sanofi Aventis DeutschlandAccord Healthcare, Accord Healthcare AB, Accord Healthcare Italia, Accord Healthcare SLU
ORD_22246/2025May 11, 2025Sanofi Aventis DeutschlandBetapharm Arzneimittel, DR Reddys, Reddy Pharma

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -